| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d2133f7c88849e3bc4a17eac589a179 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0433 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 |
| filingDate |
1999-09-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77fdd960d608896abbe5a0c8504006d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f49ee4490075633e4e7ad58f746386c |
| publicationDate |
2001-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1113823-A2 |
| titleOfInvention |
Chiral radio-contrast agents |
| abstract |
An imaging or contrast agent comprising a stereoisomer of a compound with at least one chiral centre, wherein said stereoisomer is in stereoisomeric excess and causes fewer adverse side effects on administration, or is less chemotoxic, than at least one other stereoisomer of said chiral compound. |
| priorityDate |
1998-09-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |